Dr. James Charles Fox has served as Independent NonExecutive Chairman of the Board of Biota Holdings Ltd since February 27, 2009. Within the Company, he is Member of the Remuneration and Nominations Committee. He has held directorship positions at Air New Zealand Limited, MS Research Ltd, GenMark Diagnostics, Inc and TTP Group PLC. He was formerly Chief Executive Officer of Vision Systems, which he led until its takeover by an Ameriacan company, Danaher. Prior to that, he held directorships at Optiscan Imaging Limited, Elders Limited and ISoft Group Ltd. He also spent seven years working as a Consultant and Director with PA Technology. He holds a Bachelor of Engineering, as well as Masters and Doctorate degrees from the University of Melbourne.
Non-Executive Chairman of the Board
Chairman Since 2009
The company has return on total asset (ROA) of (15.95) % which means that it has lost $15.95 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (27.83) % meaning that it generated substantial loss on money invested by shareholders.
Entity SummaryBiota Holdings Limited engages in the drug discovery and clinical development of antiinfectives in Australia. Biota Pharmaceuticals Inc [BTA] is traded on Australian Securities Exchange in Australia. It is located in Notting Hill, VIC and employs 15 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| BTA Australian #AU000000BTA1AU
Biota Pharmaceuticals Inc
Currency: AUD - Australian Dollar
Traded on Australian Securities Exchange
Biota Pharmaceuticals Inc has more than 78.4 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Promote Biota and James Fox